CLINICAL_TRIALS
trial_result
· 2025-05-09
Clinical Trial Update: A Study to Evaluate the Safety and Tolerability of EXN407 [Phase 1, Phase 2]
Summary
The study of EXN407 in diabetic macular edema completed Phase 1 and Phase 2 with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Exonate Limited | Conditions: Diabetic Macular Edema | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2025-05-09